PTC Therapeutics, Inc. Common Stock (NASDAQ: PTCT) last traded at $62.92, down 2.75% on the session. The quote above updates while this page is open; the figures below are drawn from PTC Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
PTC Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker PTCT. Its market capitalisation is $5.25 billion.
Valuation measures for PTC Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.25B |
|---|---|
| Enterprise value | $7.62B |
| Price / sales | 5.21 |
| Beta | 0.71 |
Trailing-twelve-month figures tagged in PTC Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $1.01B |
| Net income (TTM) | -$38.38M |
|---|
| EPS (TTM) | -$0.540 |
|---|
| Operating margin | 12.45% |
|---|
| Cash | $1.05B |
|---|
Range and volume for PTCT over the past 52 weeks.
| 52-week high | $90.87 |
|---|---|
| 52-week low | $61.23 |
| Volume | 740.4K |
| Average volume | 1.14M |
| Previous close | $64.70 |
Invest a chosen dollar amount in PTC Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PTCT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.